Blogs

Fine-tuning embedding models is a game-changer for improving retrieval performance and ensuring context-aware outputs with lesser latency.

Meet Agentic RAG—where Retrieval-Augmented Generation meets agent-like decision-making, powered by reinforcement learning.

In Retrieval-Augmented Generation (RAG), accurate and relevant information retrieval is crucial for generating high-quality responses. However, traditional retrieval methods often return results that are not optimally ranked for relevance. This is where **reranking** comes into play, significantly improving retrieval system performance.

Embedding Model converts texts, words, images into numerical form known as vectors, Vectors are used for Context and Relationships between texts, words, they are stored in Vector Database.

The effectiveness of a RAG system heavily depends on one fundamental preprocessing step: chunking.

From generating human-like text to automating customer support and assisting with research, LLMs are changing the way businesses and individuals access and process information.

PibyThree prioritizes security and compliance by integrating industry-best practices into every aspect of its GenAI applications.

Our tailored AI services focus on real-world applications, ensuring that businesses unlock the full potential of GenAI for sustained efficiency and innovation.

This article breaks down the fundamental differences between AI and Generative AI, exploring how they work, their applications, and their impact on various fields.

Generative AI (GenAI) is often discussed in the context of Retrieval-Augmented Generation (RAG), a method that enhances AI responses with real-time data. While RAG is a powerful technique, it is far from the full picture of what GenAI can do.

In a hyper-competitive world where every moment counts, businesses are turning to AI and cloud technologies to deliver faster, smarter, and more personalized experiences.

What comes to mind when you hear "generative AI"? Probably ChatGPT crafting a quick reply or drafting an email, right?

Every year, millions of patients wait—sometimes in vain—for life-saving medications that take too long to develop.